Am Heart J
- DAUBERT MA, Stebbins A, Peragallo-Urrutia R, Chiswell K, et al
Early Postpartum Blood Pressure Screening is Associated with Increased Detection
of Cardiovascular Risk Factors in Women with Hypertensive Disorders of Pregnancy.
Am Heart J. 2024 Apr 4:S0002-8703(24)00076-0. doi: 10.1016/j.ahj.2024.
Am J Cardiol
- SAHA A, Li S, de Lemos JA, Pandey A, et al
Characteristics of High-Performing Hospitals in Cardiogenic Shock Following Acute
Myocardial Infarction.
Am J Cardiol. 2024 Apr 5:S0002-9149(24)00237.
- CHEEMA HA, Bhanushali K, Sohail A, Fatima A, et al
Immediate Versus Staged Complete Revascularization in Patients With Acute
Coronary Syndrome: a Systematic Review and Meta-Analysis of Randomized Controlled
Trials.
Am J Cardiol. 2024 Apr 4:S0002-9149(24)00239.
- WIDMER RJ, Hammonds K, Mixon T, Exaire JE, et al
Acute coronary syndrome revascularization strategies with multi-vessel coronary
artery disease.
Am J Cardiol. 2024 Apr 4:S0002-9149(24)00236.
- REVANKAR S, Agarwala A
Stepping Away from the Monolith: The Disaggregation of Asian Cardiovascular Data.
Am J Cardiol. 2024 Apr 4:S0002-9149(24)00231.
Angiology
- MURAT B, Murat S, Gorenek B
Comment on the Association of Coronary Artery Severity and Late In-Stent
Restenosis: An Angiographic Imaging Study.
Angiology. 2024 Apr 9:33197241246917. doi: 10.1177/00033197241246917.
Ann Intern Med
- GREENWOOD H, Barnes K, Clark J, Ball L, et al
Long-Term Effect of Salt Substitution for Cardiovascular Outcomes : A Systematic
Review and Meta-Analysis.
Ann Intern Med. 2024 Apr 9. doi: 10.7326/M23-2626.
-
Annals Video Summary - Long-Term Effect of Salt Substitution for Cardiovascular
Outcomes: A Systematic Review and Meta-analysis.
Ann Intern Med. 2024 Apr 9:eM240208. doi: 10.7326/M24-0208.
Arterioscler Thromb Vasc Biol
- SELVARAJAN I, Kiema M, Huang RT, Li J, et al
Coronary Artery Disease Risk Variant Dampens the Expression of CALCRL by Reducing
HSF Binding to Shear Stress Responsive Enhancer in Endothelial Cells In Vitro.
Arterioscler Thromb Vasc Biol. 2024 Apr 11. doi: 10.1161/ATVBAHA.123.318964.
Atherosclerosis
- RINALDI R, Colucci M, Torre I, Ausiello D, et al
Predicting the response to acetylcholine in ischemia or infarction with
non-obstructive coronary arteries: The ABCD score.
Atherosclerosis. 2024;391:117503.
- HAN Y, Ren L, Fei X, Wang J, et al
Effect of combining evolocumab with statin on carotid intraplaque
neovascularization in patients with premature coronary artery disease (EPOCH).
Atherosclerosis. 2024;391:117471.
- GAGNON E, Arsenault BJ
Drug target Mendelian randomization supports apolipoprotein C3-lowering for
lipoprotein-lipid levels reductions and cardiovascular diseases prevention.
Atherosclerosis. 2024;391:117501.
Can J Cardiol
- ROBERT YAO RJ, Fordyce CB
Optimal transfusion threshold for anemic patients presenting with myocardial
infarction and heart failure: dream or REALITY?
Can J Cardiol. 2024 Apr 9:S0828-282X(24)00299-X. doi: 10.1016/j.cjca.2024.
Chest
- ARON J, Baldomero AK, Rau A, Fiecas MB, et al
Individual Risk Factors of PM(2.5) Associated With Wintertime Mortality in Urban
Patients With COPD.
Chest. 2024;165:825-835.
Circ Cardiovasc Interv
- HARKIN KL, Loftspring E, Beaty W, Joa A, et al
Visual Estimates of Coronary Slow Flow Are Not Associated with Invasive
Wire-Based Diagnoses of Coronary Microvascular Dysfunction.
Circ Cardiovasc Interv. 2024 Apr 7. doi: 10.1161/CIRCINTERVENTIONS.123.013902.
Circ Cardiovasc Qual Outcomes
- WADHERA RK, Secemsky EA, Xu J, Yeh RW, et al
Community Socioeconomic Status, Acute Cardiovascular Hospitalizations, and
Mortality in Medicare, 2003 to 2019.
Circ Cardiovasc Qual Outcomes. 2024 Apr 10:e010090.
Circ Genom Precis Med
- HENRY J, Lin Y, Bouatia-Naji N
Enhancing the Prediction Power of Polygenic Risk Scores in Genetically Diverse
Coronary Heart Disease.
Circ Genom Precis Med. 2024 Apr 8:e004610. doi: 10.1161/CIRCGEN.124.004610.
Circ J
- KIM CH, Lee SH, Kim HK, Kim MC, et al
Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide in Patients
With Non-ST-Elevation Myocardial Infarction.
Circ J. 2024 Apr 11. doi: 10.1253/circj.CJ-24-0129.
Circulation
- HERNANDEZ AF, Udell JA, Jones WS, Anker SD, et al
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial
Infarction: Insights from the EMPACT-MI Trial.
Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.124.069217.
- GOLDFARB MJ, Saylor MA, Bozkurt B, Code J, et al
Patient-Centered Adult Cardiovascular Care: A Scientific Statement From the
American Heart Association.
Circulation. 2024 Apr 11. doi: 10.1161/CIR.0000000000001233.
- PATEL SM, Kang YM, Im K, Neuen BL, et al
Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular
Outcomes: A SMART-C Collaborative Meta-Analysis.
Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069568.
- FANAROFF AC, Patel MS, Chokshi N, Coratti S, et al
Effect of Gamification, Financial Incentives, or Both to Increase Physical
Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE
Randomized Controlled Trial.
Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069531.
- CHO L, Plutzky J, Brennan D, Louie MJ, et al
Impact of Bempedoic Acid on Cardiovascular Outcomes by Sex.
Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.123.067691.
Eur Heart J
- BHATT AS, Johansen ND, Modin D, Claggett BL, et al
Electronic nudges increase influenza vaccination utilization after myocardial
infarction: the nationwide NUDGE-FLU implementation trial.
Eur Heart J. 2024 Apr 10:ehae235. doi: 10.1093.
- CREA F
The complex interaction between cancer, ischaemic heart disease, and heart
failure, and a focus on arrhythmias including risk stratification in Brugada
syndrome and leadless pacing.
Eur Heart J. 2024;45:1183-1187.
- KASKI JC, Al-Lamee R, Boden WE
The year in cardiovascular medicine 2023: the top 10 papers in ischaemic heart
disease.
Eur Heart J. 2024;45:1201-1204.
- AMERI P, Bertero E, Lombardi M, Porto I, et al
Ischaemic heart disease in patients with cancer.
Eur Heart J. 2024;45:1209-1223.
- BYRNE R, Coughlan JJ, Rossello X, Ibanez B, et al
The '10 commandments' for the 2023 ESC Guidelines for the management of acute
coronary syndromes.
Eur Heart J. 2024;45:1193-1195.
- CALLEGARI A, Bonnet D, Malekzadeh-Milani S
Successful percutaneous treatment of perinatal complete left coronary thrombotic
occlusion.
Eur Heart J. 2024;45:1285.
- LU ZN, Yang Y, Song G
A patient-tailored clipping strategy of transcatheter edge-to-edge repair as
salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet
flails.
Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
Hypertension
- DZIEDZIC M, Jozefczuk E, Guzik TJ, Siedlinski M, et al
Interplay Between Plasma Glycine and Branched-Chain Amino Acids Contributes to
the Development of Hypertension and Coronary Heart Disease.
Hypertension. 2024 Apr 8. doi: 10.1161/HYPERTENSIONAHA.123.22649.
Int J Cardiol
- UELAND T, Butt N, Lekva T, Orn S, et al
High dose statin treatment reduces circulating Dickkopf-1 following acute
myocardial infarction.
Int J Cardiol. 2024 Apr 9:132035. doi: 10.1016/j.ijcard.2024.132035.
- YILDIRIM M, Giannitsis E, Mueller-Hennessen M
Reply to: Kavsak et al. The clinical chemistry score (CCS) achieves the highest
efficacy when assessed with the 99% sensitivity benchmark for myocardial
infarction.
Int J Cardiol. 2024 Apr 6:132030. doi: 10.1016/j.ijcard.2024.132030.
- CHENG Y, Zhang Q
Comment on "Subclinical myocardial injury increases the risk of heart failure in
patients with and without type 2 diabetes post-acute coronary syndrome".
Int J Cardiol. 2024 Mar 26:131979. doi: 10.1016/j.ijcard.2024.131979.
- MCCHORD J, Ong P
Advancing precision medicine in INOCA research: The INOCA-IT registry.
Int J Cardiol. 2024;404:131975.
- SHIBA M, Kato T, Seko Y, Minamino-Muta E, et al
Cobalt protoporphyrin promotes heme oxygenase 1 expression and ameliorates
cardiac dysfunction in long-term fasting mice.
Int J Cardiol. 2024;404:131972.
- STERPETTI AV, Gabriele R, Di Marzo L
Sex disparities for clinical outcomes after percutaneous coronary intervention
for acute coronary syndrome.
Int J Cardiol. 2024;404:131937.
- BACIGALUPI E, Pelliccia F, Zimarino M
Diabetes mellitus and in-stent restenosis: A direct link or something more?
Int J Cardiol. 2024;404:131922.
- GOLINO M, Harding D, Del Buono MG, Fanti S, et al
Innate and adaptive immunity in acute myocarditis.
Int J Cardiol. 2024;404:131901.
J Am Coll Cardiol
- POVSIC TJ, Korjian S, Bahit MC, Chi G, et al
Effect of CSL112 on Recurrent Myocardial Infarction and Cardiovascular Death:
Insights from the AEGIS-II Trial.
J Am Coll Cardiol. 2024 Mar 25:S0735-1097(24)06702.
- UDELL JA, Petrie MC, Jones WS, Anker SD, et al
Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart
Failure Risk After Myocardial Infarction.
J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)06757.
- ELIAS P, Jain S, Poterucha T, Randazzo M, et al
Artificial Intelligence for Cardiovascular Care - Part 1: Advances: JACC Review
Topic of the Week.
J Am Coll Cardiol. 2024 Mar 26:S0735-1097(24)06742.
- BOROVAC JA
Unlocking the Gates of ISCHEMIA: Moving Toward Personalized Angina Management for
Chronic Coronary Syndrome.
J Am Coll Cardiol. 2024;83:1367-1369.
- ARNOLD SV, Jones PG, Maron DJ, Cohen DJ, et al
Variation in Health Status With Invasive vs Conservative Management of Chronic
Coronary Disease.
J Am Coll Cardiol. 2024;83:1353-1366.
- JAIN S, Elias P, Poterucha T, Randazzo M, et al
Artificial Intelligence in Cardiovascular Care - Part 2: Applications: JACC
Review Topic of the Week.
J Am Coll Cardiol. 2024 Mar 26:S0735-1097(24)06744.
- OKOH AK, Amponsah MKD, Cheffet-Walsh S, Patel M, et al
Prevalence of Cardiovascular Disease and Risk Factors among National Football
League Alumni and Family Members.
J Am Coll Cardiol. 2024 Mar 12:S0735-1097(24)00988.
- ALSHAHRANI NS, Hartley A, Howard J, Hajhosseiny R, et al
Remote Acute Assessment of Cardiac Patients Post-Acute Coronary Syndrome
(TELE-ACS): A Randomized Controlled Trial.
J Am Coll Cardiol. 2024 Mar 28:S0735-1097(24)06709.
- MINHAS AMK, Mathew RO, Sperling LS, Nambi V, et al
Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States.
J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)00940.
J Cardiovasc Pharmacol
- ZHANG M, Peng W, Yin S, Zhao Y, et al
Nondual Antiplatelet Therapy Versus Dual Antiplatelet Therapy Before
Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis.
J Cardiovasc Pharmacol. 2024;83:297-305.
J Clin Endocrinol Metab
- SONG X, Xiong L, Guo T, Chen X, et al
Cystatin C is a predictor for long-term All-Cause and Cardiovascular Mortality in
US Adults with Metabolic Syndrome.
J Clin Endocrinol Metab. 2024 Apr 10:dgae225. doi: 10.1210.
J Mol Cell Cardiol
- ANTIPENKO S, Mayfield N, Jinno M, Gunzer M, et al
Neutrophils are indispensable for adverse cardiac remodeling in heart failure.
J Mol Cell Cardiol. 2024;189:1-11.
JAMA
- HARRIS E
Study Examines Intermittent Fasting and Cardiovascular Mortality.
JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5158.
- WU F, Jacobs DR Jr, Daniels SR, Kahonen M, et al
Non-High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and
Cardiovascular Disease Events.
JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4819.
Lancet
- STEINER-GAGER GM, Siller-Matula JM
Abbreviated dual antiplatelet therapy after acute coronary syndrome.
Lancet. 2024 Apr 5:S0140-6736(24)00586-5. doi: 10.1016/S0140-6736(24)00586.
- GE Z, Kan J, Gao X, Raza A, et al
Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after
percutaneous coronary intervention in patients with acute coronary syndromes
(ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.
Lancet. 2024 Apr 5:S0140-6736(24)00473-2. doi: 10.1016/S0140-6736(24)00473.
- BOROVAC JA
Percutaneous coronary intervention for non-obstructive vulnerable plaques.
Lancet. 2024 Apr 4:S0140-6736(24)00488-4. doi: 10.1016/S0140-6736(24)00488.
- DEN DEKKER WK
Is intravascular imaging the future of percutaneous coronary intervention?
Lancet. 2024 Apr 5:S0140-6736(24)00430-6. doi: 10.1016/S0140-6736(24)00430.
- LI X, Ge Z, Kan J, Anjum M, et al
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary
intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre,
randomised trial.
Lancet. 2024 Apr 5:S0140-6736(24)00282-4. doi: 10.1016/S0140-6736(24)00282.
- PARK SJ, Ahn JM, Kang DY, Yun SC, et al
Preventive percutaneous coronary intervention versus optimal medical therapy
alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT):
a multicentre, open-label, randomised controlled trial.
Lancet. 2024 Apr 4:S0140-6736(24)00413-6. doi: 10.1016/S0140-6736(24)00413.
Mol Cell Biochem
- YANG X, Wu H, Zhou G, Zhang D, et al
Autosis: a new form of cell death in myocardial ischemia-reperfusion injury.
Mol Cell Biochem. 2024 Apr 9. doi: 10.1007/s11010-024-04988.
N Engl J Med
- BERGMARK BA, Marston NA, Prohaska TA, Alexander VJ, et al
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk.
N Engl J Med. 2024 Apr 7. doi: 10.1056/NEJMoa2402309.
- KUNADIAN V
Role of Physiology in the Management of Nonculprit Lesions in Acute Coronary
Syndrome.
N Engl J Med. 2024 Apr 8. doi: 10.1056/NEJMe2403527.
- MANRIQUE-ACEVEDO C, Hirsch IB, Eckel RH
Prevention of Cardiovascular Disease in Type 1 Diabetes.
N Engl J Med. 2024;390:1207-1217.
- BUTLER J, Jones WS, Udell JA, Anker SD, et al
Empagliflozin after Acute Myocardial Infarction.
N Engl J Med. 2024 Apr 6. doi: 10.1056/NEJMoa2314051.
- YNDIGEGN T, Lindahl B, Mars K, Alfredsson J, et al
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.
N Engl J Med. 2024 Apr 7. doi: 10.1056/NEJMoa2401479.
- ROULEAU J
Decreasing the Risk of Heart Failure in a Changing Post-Myocardial Infarction
Environment.
N Engl J Med. 2024 Apr 6. doi: 10.1056/NEJMe2402719.
- GIBSON CM, Duffy D, Korjian S, Bahit MC, et al
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial
Infarction.
N Engl J Med. 2024 Apr 6. doi: 10.1056/NEJMoa2400969.
- BOHM F, Mogensen B, Engstrom T, Stankovic G, et al
FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction.
N Engl J Med. 2024 Apr 8. doi: 10.1056/NEJMoa2314149.
PLoS One
- CAO Y, Feng Y, Xia N, Zhang J, et al
Causal associations of particulate matter 2.5 and cardiovascular disease: A
two-sample mendelian randomization study.
PLoS One. 2024;19:e0301823.
- EL-MALAHI O, Mohajeri D, Mincu R, Bauerle A, et al
Beneficial impacts of physical activity on heart rate variability: A systematic
review and meta-analysis.
PLoS One. 2024;19:e0299793.
- ZHANG Z, Chen Y, Fu X, Chen L, et al
Identification of PPARG as key gene to link coronary atherosclerosis disease and
rheumatoid arthritis via microarray data analysis.
PLoS One. 2024;19:e0300022.
- WU J, Tao G, Xiao H
Association of different milk fat content with coronary artery disease and
myocardial infarction risk: A Mendelian randomization study.
PLoS One. 2024;19:e0300513.
Prog Cardiovasc Dis
- JAISWAL V, Sawhney A, Nebuwa C, Borra V, et al
Association between testosterone replacement therapy and cardiovascular outcomes:
A meta-analysis of 30 randomized controlled trials.
Prog Cardiovasc Dis. 2024 Apr 5:S0033-0620(24)00055.
Psychosom Med
- CONNOR A, Deschamps A, Busque L, Tardif JC, et al
Childhood Maltreatment and Leukocyte Telomere Length: Cardiac Vagal Activity
Influences the Relation in Older Adults.
Psychosom Med. 2024;86:146-156.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016